The q1 MD&A today says the product will be ready for sale by June - beginning or end? The Company’s biomarker development process continues to progress. The Company is currently testing to determine if the biomarker transfers through the extraction process into cannabis or hemp oil. Equipment has been purchased to increase the Company’s capacity to manufacture the biomarker and it is being utilized to increase the number of plants the biomarker can be applied to. Negotiations with potential commercialization partners continues to progress as many cannabis and hemp growers are recognizing the value of true seed to sale traceability.
News 
Market Data 
Discover 
